NCT00414960View on ClinicalTrials.gov

A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Lung Cancer
Interventions
DRUG

Enzastaurin

500 mg po QD for 6 months

DRUG

Placebo

po QD for 6 months

Trial Locations (1)

33612

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampa

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00414960 - A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers | Biotech Hunter | Biotech Hunter